comparemela.com
Home
Live Updates
60 Degrees Pharmaceuticals to Sponsor Pilot Study of : comparemela.com
60 Degrees Pharmaceuticals to Sponsor Pilot Study of
60 Degrees Pharma (Nasdaq: SXTP) will sponsor a study using tafenoquine, an FDA-approved malaria drug, to treat canine babesiosis, a tick-borne disease....
Related Keywords
Australia
,
Washington
,
United States
,
Australian
,
Patrick Gaynes
,
Sheilaa Burke
,
United States Army
,
Exchange Commission
,
Materiel Development Activity
,
Degrees Pharmaceuticals Inc
,
Drug Administration
,
Degrees Pharmaceuticals
,
Company Type
,
Walter Reed Army Institute Of Research
,
Carolina State University
,
North Carolina State University
,
Canine Babesiosis Pilot
,
Institutional Animal Care
,
Use Committee
,
Walter Reed Army Institute
,
Materiel Development
,
Institutional Review Board
,
Investigational New Drug Application
,
Investigational New Drug
,
Securities Litigation Reform Act
,
Registration Statement
,
Nasdaq Sxtp
,
Sixty Degrees Pharmaceuticals
,
60 Degrees Pharmaceuticals
,
Anine Babesiosis
,
Afenoquine
,
Rakoda 174
,
North Carolina State
,
Specialty Pharma
,
Biotech
,
Nasdaq
,
Nxtp
,
comparemela.com © 2020. All Rights Reserved.